| Optimum Living Psychology, Pllc | |
|
111 W Main St Ste 307 Inverness FL 34450-4807 | |
| (352) 201-4955 | |
| Not Available |
| Full Name | Optimum Living Psychology, Pllc |
|---|---|
| Speciality | Psychologist |
| Location | 111 W Main St Ste 307, Inverness, Florida |
| Authorized Official Name and Position | Faith Powers (LICENSED PSYCHOLOGIST/OWNER) |
| Authorized Official Contact | 3522014955 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Optimum Living Psychology, Pllc 111 W Main St Ste 307 Inverness FL 34450-4807 Ph: (352) 201-4955 | Optimum Living Psychology, Pllc 111 W Main St Ste 307 Inverness FL 34450-4807 Ph: (352) 201-4955 |
| NPI Number | 1609425016 |
|---|---|
| Provider Enumeration Date | 09/09/2019 |
| Last Update Date | 09/09/2019 |
| Medicare PECOS PAC ID | 4981933041 |
|---|---|
| Medicare Enrollment ID | O20190916000926 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.
A new study, published in the journal Human Psychopharmacology: Clinical and Experimental, shows that the atypical antipsychotic Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia who exhibit aggressive behaviour during psychotic episodes.
Affymax, Inc. and Takeda Pharmaceutical Company Limited today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the investigational agent peginesatide for the treatment of anemia associated with chronic renal failure in adult patients on dialysis.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609425016 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Provider Name | Faith J Powers |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1740587328 PECOS PAC ID: 5890973143 Enrollment ID: I20110711000184 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.
A new study, published in the journal Human Psychopharmacology: Clinical and Experimental, shows that the atypical antipsychotic Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia who exhibit aggressive behaviour during psychotic episodes.
Affymax, Inc. and Takeda Pharmaceutical Company Limited today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the investigational agent peginesatide for the treatment of anemia associated with chronic renal failure in adult patients on dialysis.
› Verified 1 days ago
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.
A new study, published in the journal Human Psychopharmacology: Clinical and Experimental, shows that the atypical antipsychotic Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia who exhibit aggressive behaviour during psychotic episodes.
Affymax, Inc. and Takeda Pharmaceutical Company Limited today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the investigational agent peginesatide for the treatment of anemia associated with chronic renal failure in adult patients on dialysis.
› Verified 1 days ago
Parmanand Gurnani, M.d., P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3787 E Gulf To Lake Hwy, Inverness, FL 34453 Phone: 352-726-3950 Fax: 352-726-7582 | |
Beena M Stanley Md Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 511 W Highland Blvd, Inverness, FL 34452 Phone: 352-860-0202 Fax: 352-860-1918 | |
Achievement Rehabilitation Through Therapeutic Intervention Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 130 Heights Ave, Inverness, FL 34452 Phone: 352-419-6570 | |
Donald E Fedor Ms,lmhc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3565 E Suzie Ln, Inverness, FL 34452 Phone: 352-344-4497 | |
Achievement Rehabilitation Through Therapeutic Intervention, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 130 Heights Ave, Inverness, FL 34452 Phone: 352-419-6570 Fax: 888-639-2521 | |
Therapeutic Health Endeavors Institute Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3565 E Suzie Ln, Inverness, FL 34452 Phone: 352-476-4364 | |
Clinical Health Psychology Associates, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 957 S. Lois Terrace, Suite 102, Inverness, FL 34452 Phone: 352-341-0200 Fax: 352-341-0700 |